Clinical Trial Update: A Phase Ib/IIa, Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

Phase Ib/IIa, double-blind, randomized study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of S-777469 in subjects with atopic der…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• S-777469

Snippet

Sponsor: Shionogi | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: COMPLETED